Literature DB >> 12095938

Antiestrogenic regulation of transforming growth factor beta receptors I and II in human breast cancer cells.

M Buck1, J von der Fecht, C Knabbe.   

Abstract

To obtain more information about the interactions between antiestrogens and transforming growth factor beta (TGF-beta) signaling, we analyzed the influence of different types of antiestrogens on the expression of TGF-beta receptors I (TbetaRI) and II (TbetaRII). Our results show that antiestrogens selectively induce TbetaRII but not TbetaRI mRNA.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12095938     DOI： 10.1111/j.1749-6632.2002.tb04104.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  3 in total

1.  A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER(+), PR(+), ER(+)PR(+) and HER2(-) expression in women.

Authors:  Mei Zhang; Ling-Ling Guo; Zhongqin Cheng; Reng-Yun Liu; Yufeng Lu; Qian Qian; Zhe Lei; Hong-Tao Zhang
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

Review 2.  Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Authors:  Antoinette R Tan; Gabriela Alexe; Michael Reiss
Journal:  Breast Cancer Res Treat       Date:  2008-10-09       Impact factor: 4.872

3.  Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.

Authors:  Abeer Bahhnassy; Marwa Mohanad; Sabry Shaarawy; Manal F Ismail; Ahmed El-Bastawisy; Abeer M Ashmawy; Abdel-Rahman Zekri
Journal:  Mol Med Rep       Date:  2015-03-27       Impact factor: 2.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.